Research Article

Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease

Volume: 11 Number: 1 March 15, 2026
TR EN

Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease

Abstract

Objective: Peripheral Artery Disease (PAD) is the third leading cause of cardiovascular morbidity worldwide. Given their established roles in lipid metabolism, the lectin-complement pathway, and endoplasmic reticulum stress, we aimed to investigate the potential involvement of the FBXW7, MASP1, and SERP1 genes in PAD. This study sought to evaluate whether these genes could serve as non-invasive biomarkers for the diagnosis of PAD, as they have not been previously explored in this patient population. Materials and Methods: A total of 78 individuals with peripheral arterial disease and 76 healthy individuals were included in the study. Total RNA was extracted from blood samples, and the expressions of FBXW7, MASP1, and SERP1 mRNAs were determined using the real-time polymerase chain reaction (rt-PCR). Results: No statistically significant differences were observed in the expression levels of FBXW7, MASP1, and SERP1 genes between PAD patients and healthy subjects (p > 0.05). Conclusion: Although FBXW7, MASP1, and SERP1 proteins are associated with arterial function, they do not appear to play a direct role in the development of peripheral artery disease.

Keywords

Supporting Institution

The project was supported by the University of Health Sciences Türkiye, Unit of Scientific Research Projects (project no: 2019/035).

Ethical Statement

Ethical approval for the study was obtained from the XXX High Specialization Education and Research Hospital, Clinical Research Ethics Committee (Date: 20.12.2018, decision no: 2018/7/72). The study was conducted in accordance with the Declaration of Helsinki.

References

  1. 1. SHI Y, XU X, LUAN P, et al. miR-124-3p regulates angiogenesis in peripheral arterial disease by targeting STAT3. Mol Med Rep. 2020;22(6):4890-4898.
  2. 2. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509-1526.
  3. 3. Stojkovic S, Jurisic M, Kopp CW, et al. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation. Atherosclerosis. 2018;269:197-203.
  4. 4. Hiatt WR, Armstrong EJ, Larson CJ, Brass EP. Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease. Circ Res. 2015;116(9):1527-1539.
  5. 5. Firnhaber JM, Powell CS. Lower extremity peripheral artery disease: Diagnosis and treatment. Am Fam Physician. 2019;99(6):362-369.
  6. 6. Fowkes FGR, Aboyans V, Fowkes FJI, McDermott MM, Sampson UKA, Criqui MH. Peripheral artery disease: Epidemiology and global perspectives. Nat Rev Cardiol. 2017;14(3):156-170.
  7. 7. Bauersachs R, Zeymer U, Brière JB, Marre C, Bowrin K, Huelsebeck M. Burden of coronary artery disease and peripheral artery disease: A literature review. Cardiovasc Ther. 2019;2019:8295054. doi:10.1155/2019/8295054
  8. 8. Bengoechea-Alonso MT, Ericsson J. The phosphorylation-dependent regulation of nuclear SREBP1 during mitosis links lipid metabolism and cell growth. Cell Cycle. 2016;15(20):2753-2765.

Details

Primary Language

English

Subjects

Cardiovascular Surgery

Journal Section

Research Article

Publication Date

March 15, 2026

Submission Date

October 30, 2025

Acceptance Date

February 9, 2026

Published in Issue

Year 2026 Volume: 11 Number: 1

APA
Erdoğan, B., Kuraş, S., Yıılmaz, F., Hacımustafaoğlu, F., Pençe, M. E., & Pence, H. H. (2026). Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. Online Turkish Journal of Health Sciences, 11(1), 16-23. https://doi.org/10.26453/otjhs.1812461
AMA
1.Erdoğan B, Kuraş S, Yıılmaz F, Hacımustafaoğlu F, Pençe ME, Pence HH. Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. OTJHS. 2026;11(1):16-23. doi:10.26453/otjhs.1812461
Chicago
Erdoğan, Bekir, Sibel Kuraş, Fatih Yıılmaz, Fatih Hacımustafaoğlu, Mahmud Esad Pençe, and Halime Hanim Pence. 2026. “Investigation of FBXW7, MASP1 and SERP1 MRNA Expression Levels in Patients With Peripheral Artery Disease”. Online Turkish Journal of Health Sciences 11 (1): 16-23. https://doi.org/10.26453/otjhs.1812461.
EndNote
Erdoğan B, Kuraş S, Yıılmaz F, Hacımustafaoğlu F, Pençe ME, Pence HH (March 1, 2026) Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. Online Turkish Journal of Health Sciences 11 1 16–23.
IEEE
[1]B. Erdoğan, S. Kuraş, F. Yıılmaz, F. Hacımustafaoğlu, M. E. Pençe, and H. H. Pence, “Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease”, OTJHS, vol. 11, no. 1, pp. 16–23, Mar. 2026, doi: 10.26453/otjhs.1812461.
ISNAD
Erdoğan, Bekir - Kuraş, Sibel - Yıılmaz, Fatih - Hacımustafaoğlu, Fatih - Pençe, Mahmud Esad - Pence, Halime Hanim. “Investigation of FBXW7, MASP1 and SERP1 MRNA Expression Levels in Patients With Peripheral Artery Disease”. Online Turkish Journal of Health Sciences 11/1 (March 1, 2026): 16-23. https://doi.org/10.26453/otjhs.1812461.
JAMA
1.Erdoğan B, Kuraş S, Yıılmaz F, Hacımustafaoğlu F, Pençe ME, Pence HH. Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. OTJHS. 2026;11:16–23.
MLA
Erdoğan, Bekir, et al. “Investigation of FBXW7, MASP1 and SERP1 MRNA Expression Levels in Patients With Peripheral Artery Disease”. Online Turkish Journal of Health Sciences, vol. 11, no. 1, Mar. 2026, pp. 16-23, doi:10.26453/otjhs.1812461.
Vancouver
1.Bekir Erdoğan, Sibel Kuraş, Fatih Yıılmaz, Fatih Hacımustafaoğlu, Mahmud Esad Pençe, Halime Hanim Pence. Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. OTJHS. 2026 Mar. 1;11(1):16-23. doi:10.26453/otjhs.1812461

Creative Commons License
 

Online Türk Sağlık Bilimleri Dergisi [Online Turkish Journal of Health Sciences (OTJHS)] is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an open-access journal distributed under the terms of the Creative Commons Attribution License (CC BY-NC 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or name of the journal is credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Click here to get help about article submission processes and "Copyright Transfer Form".